about
Clinical pathophysiology of human T-lymphotropic virus-type 1-associated myelopathy/tropical spastic paraparesisAPOBEC3A, APOBEC3B, and APOBEC3H haplotype 2 restrict human T-lymphotropic virus type 1Immunogenetics and the Pathological Mechanisms of Human T-Cell Leukemia VirusType 1- (HTLV-1-)Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP).HAM/TSP-derived HTLV-1-infected T cell lines promote morphological and functional changes in human astrocytes cell lines: possible role in the enhanced T cells recruitment into Central Nervous SystemImmunopathogenesis of human T-cell leukemia virus type-1-associated myelopathy/tropical spastic paraparesis: recent perspectivesIncreased expression of OX40 is associated with progressive disease in patients with HTLV-1-associated myelopathy/tropical spastic paraparesisEndemic impact of human T cell leukemia virus type 1 screening in bone allografts.No Evidence of HTLV-II Infection Among Immonoblot Indeterminate Samples Using Nested PCR in Mashhad, Northeast of Iran.Dermatological manifestations of individuals infected with human T cell lymphotropic virus type I (HTLV-I).The motor evoked potential in AIDS and HAM/TSP: state of the evidence.Neuroimmunological aspects of human T cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis.A critical role for IL-17RB signaling in HTLV-1 tax-induced NF-κB activation and T-cell transformation.Cross-reactive antibodies to target proteins are dependent upon oligomannose glycosylated epitopes in HTLV-1 associated neurological disease.Atrophy, focal spinal cord lesions and alterations of diffusion tensor imaging (DTI) parameters in asymptomatic virus carriers and patients suffering from human T-lymphotrophic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesisSimultaneous RNA quantification of human and retroviral genomes reveals intact interferon signaling in HTLV-1-infected CD4+ T cell lines.The CC chemokine ligand (CCL) 1, upregulated by the viral transactivator Tax, can be downregulated by minocycline: possible implications for long-term treatment of HTLV-1-associated myelopathy/tropical spastic paraparesis.
P2860
Q21131133-059BFEE5-4467-42FB-AF8D-604621615C1CQ24310242-77145527-7811-458A-AA2F-5E396C81860AQ33651831-2D32D214-8064-4FFD-9A25-F0695AD7AC80Q36156395-F86BF839-F301-46B4-A2BA-3BF87F1EFA63Q36422111-08D08FC6-2E8A-40FB-BFBB-743494D326E8Q36859157-DB2183B9-D336-4BDC-B578-F7A427B42933Q37423645-A74D9436-FA09-4D03-BB16-10FC2077C5C6Q37435359-F43E7063-C734-4F3A-80E3-6F0894EAC04EQ37672616-89C7601B-2E53-4DD5-8817-4281E32F8C9CQ37673010-7FD62B60-ABEC-4731-B705-5A22EE2E1A7DQ38128799-753186B6-43D0-4B76-A03D-DA0B55693DB7Q39162894-285C0199-839F-421C-8CE2-24EEDFCF87A1Q39167266-04137A18-B3B9-42A1-884A-62AC2CD76A60Q39560951-CB99EB1B-4BD5-4786-A98B-AA201BD49B0AQ41381866-F254361B-CD34-4168-ACA0-5F0C5B9AB6B5Q47107838-7A3530FF-45CB-419B-8129-31427A850EE4
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
HTLV-I-associated myelopathy.
@ast
HTLV-I-associated myelopathy.
@en
HTLV-I-associated myelopathy.
@nl
type
label
HTLV-I-associated myelopathy.
@ast
HTLV-I-associated myelopathy.
@en
HTLV-I-associated myelopathy.
@nl
prefLabel
HTLV-I-associated myelopathy.
@ast
HTLV-I-associated myelopathy.
@en
HTLV-I-associated myelopathy.
@nl
P2093
P2860
P1433
P1476
HTLV-I-associated myelopathy.
@en
P2093
P2860
P356
10.1046/J.1440-1789.2000.00320.X
P478
P577
2000-09-01T00:00:00Z